⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL209488 | 0.75 | — | — | |
| SCHEMBL17517389 | 0.72 | — | — | |
| SCHEMBL9814035 | 0.72 | TSHR (0.47) | — | |
| SCHEMBL28829 | 0.69 | — | — | |
| SCHEMBL5522835 | 0.69 | — | — | |
| SCHEMBL16708763 | 0.67 | — | — | |
| SCHEMBL967620 | 0.67 | — | — | |
| SCHEMBL15905679 | 0.67 | — | — | |
| SCHEMBL16653855 | 0.67 | — | — | |
| SCHEMBL17750732 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4531141-B2 | — | — | 2010-08-25 | — | — | JP | claimed |
| EP-1201237-A1 | Composition comprising an amide or a dialkylsulphoxide derivative for the treatment of cancer | Virodene Pharmaceutical Holdings (PTY) Ltd. (ZA) | 2002-05-02 | — | — | EP | claimed |
| JP-2002511862-A | — | — | 2002-04-16 | — | — | JP | claimed |
| EP-0966196-A4 | COMPOSITION FOR ORGAN CRYOPRESERVATION AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS | VIRODENE PHARMACEUTICAL HOLDIN (ZA) | 2002-03-27 | — | — | EP | claimed |
| EP-1011567-A1 | DRUG DELIVERY DEVICES AND METHODS FOR TREATMENT OF VIRAL AND MICROBIAL INFECTIONS AND WASTING SYNDROMES | Cryopreservation Technologies CC (ZA) | 2000-06-28 | — | — | EP | claimed |
| EP-1011567-A4 | DRUG DELIVERY DEVICES AND METHODS FOR TREATMENT OF VIRAL AND MICROBIAL INFECTIONS AND WASTING SYNDROMES | CRYOPRESERVATION TECH CC (ZA) | 2000-06-28 | — | — | EP | claimed |
| EP-0966196-A1 | COMPOSITION FOR ORGAN CRYOPRESERVATION AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS | Cryopreservation Technologies CC (ZA) | 1999-12-29 | — | — | EP | claimed |
| US-5935597-A | Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes | CRYOPRESERVATION TECHNOLOGIES CC (ZA) | 1999-08-10 | — | — | US | claimed |
| WO-1998056325-A1 | DRUG DELIVERY DEVICES AND METHODS FOR TREATMENT OF VIRAL AND MICROBIAL INFECTIONS AND WASTING SYNDROMES | CRYOPRESERVATION TECHNOLOGIES CC (ZA) | 1998-12-17 | — | — | WO | claimed |
| WO-1997022248-A9 | COMPOSITION FOR ORGAN CRYOPRESERVATION AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS | — | 1997-10-02 | — | — | WO | claimed |
| WO-1997022248-A1 | COMPOSITION FOR ORGAN CRYOPRESERVATION AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS | CRYOPRESERVATION TECHNOLOGIES CC (ZA) | 1997-06-26 | — | — | WO | claimed |
| WO-2009008992-A2 | COMBINATION ANTI-CANCER THERAPY COMPRISING AN INHIBITOR OF BOTH MTORC1 AND MT0RC2 | OSI PHARMACEUTICALS INC. (US) | 2009-01-15 | — | — | WO | disclosed |
| EP-1201237-A1 | Composition comprising an amide or a dialkylsulphoxide derivative for the treatment of cancer | Virodene Pharmaceutical Holdings (PTY) Ltd. (ZA) | 2002-05-02 | — | — | EP | disclosed |
| EP-0966196-A4 | COMPOSITION FOR ORGAN CRYOPRESERVATION AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS | VIRODENE PHARMACEUTICAL HOLDIN (ZA) | 2002-03-27 | — | — | EP | disclosed |
| EP-1011567-A4 | DRUG DELIVERY DEVICES AND METHODS FOR TREATMENT OF VIRAL AND MICROBIAL INFECTIONS AND WASTING SYNDROMES | CRYOPRESERVATION TECH CC (ZA) | 2000-06-28 | — | — | EP | disclosed |
| EP-0966196-A1 | COMPOSITION FOR ORGAN CRYOPRESERVATION AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS | Cryopreservation Technologies CC (ZA) | 1999-12-29 | — | — | EP | disclosed |
| US-5935597-A | Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes | CRYOPRESERVATION TECHNOLOGIES CC (ZA) | 1999-08-10 | — | — | US | disclosed |
| WO-1998056325-A1 | DRUG DELIVERY DEVICES AND METHODS FOR TREATMENT OF VIRAL AND MICROBIAL INFECTIONS AND WASTING SYNDROMES | CRYOPRESERVATION TECHNOLOGIES CC (ZA) | 1998-12-17 | — | — | WO | disclosed |
| WO-1997022248-A9 | COMPOSITION FOR ORGAN CRYOPRESERVATION AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS | — | 1997-10-02 | — | — | WO | disclosed |
| WO-1997022248-A1 | COMPOSITION FOR ORGAN CRYOPRESERVATION AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS | CRYOPRESERVATION TECHNOLOGIES CC (ZA) | 1997-06-26 | — | — | WO | disclosed |